In Uncategorized Posted
Global TB Report 2021
The WHO published the Global TB Report 2021. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the [...]
The WHO published the Global TB Report 2021. This report provides a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the [...]
New TB vaccines are on the horizon, but their success is not guaranteed. World leaders pledged to deliver at least USD $2 billion annually for TB research, including vaccines, at the 2018 United [...]
The STriTuVaD Consortium is proud to announce the recruitment of the First Patient in the STriTuVaD Clinical Trial of RUTI® Vaccine for Tuberculosis (TB). Please read the press release
2021 Pipeline Report Tuberculosis Vaccines
From 20-22 April 2021 the virtual Global Forum on Tuberculosis (TB) Vaccines took place. Please read the meeting report.
We are delighted to announce that TBVI will once again organize its annual meeting in the Swiss mountains of Les Diablerets from 18-20 January 2022. We are currently compiling the program and [...]
Zendal and IAVI announce to partner to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. For more information, please read the Press Release
a vacancy for a Project Manager at European Vaccine Initiative (EVI). It will be a full time position in Germany. For more information, please read the Job vacancy at the EVI website
Institut Pasteur-Lille is organizing an international conference on BCG in November this year. More information, registration etc. can be found here
TBVI and IAVI have updated the TB Vaccine Development Pathway. This online tool provides a structured development path and gating criteria for TB vaccine candidates and may be useful for vaccine [...]
Runderweg 6
8219 PK Lelystad
The Netherlands
Email: info@tbvi.eu
Phone: +31 320 277 550